Tech Company M&A Transactions

UNITY Biotechnology Acquisition

UNITY Biotechnology was purchased by . The deal became public on 5/2/2018. The companies indicated that total deal value was $85 million.

Transaction Overview

Acquired By
Announced On
5/2/2018
Transaction Type
M&A
Amount
$85,000,000
M&A Terms

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3280 Bayshore Blvd. 100
Brisbane, CA 94005
USA
Email Address
Overview
Unity Biotechnology (Nasdaq: UBX) Imagine a future in which you age, but without the diseases your parents got. A future in which it doesn't hurt to grow old. At UNITY, we design therapeutics that prevent, halt, or reverse diseases of aging. Our medicines are designed to lengthen healthspan, the amount of time you live in good health.
Profile
UNITY Biotechnology LinkedIn Company Profile
Social Media
UNITY Biotechnology Company Twitter Account
Company News
UNITY Biotechnology News
Facebook
UNITY Biotechnology on Facebook
YouTube
UNITY Biotechnology on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Keith Leonard
  Keith Leonard LinkedIn Profile  Keith Leonard Twitter Account  Keith Leonard News  Keith Leonard on Facebook
Chief Financial Officer
Robert Goeltz
  Robert Goeltz LinkedIn Profile  Robert Goeltz Twitter Account  Robert Goeltz News  Robert Goeltz on Facebook
Chief Medical Officer
Jamie Dananberg
  Jamie Dananberg LinkedIn Profile  Jamie Dananberg Twitter Account  Jamie Dananberg News  Jamie Dananberg on Facebook
Chief Scientific Officer
Dan Marquess
  Dan Marquess LinkedIn Profile  Dan Marquess Twitter Account  Dan Marquess News  Dan Marquess on Facebook
President
Nathaniel David
  Nathaniel David LinkedIn Profile  Nathaniel David Twitter Account  Nathaniel David News  Nathaniel David on Facebook
VP - General Counsel
Tamara Tompkins
  Tamara Tompkins LinkedIn Profile  Tamara Tompkins Twitter Account  Tamara Tompkins News  Tamara Tompkins on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/2/2018: Halo Neuroscience venture capital transaction
Next: 5/2/2018: Sentenai venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary